Covid-19 roundup: No­vavax fi­nal­ly re­ceives the go-ahead in Eu­rope for its vac­cine; CDC strug­gles to track Omi­cron

The long wait for No­vavax’s promis­ing Covid-19 vac­cine will soon be over for Eu­ro­peans.

The Eu­ro­pean Med­i­cines Agency on Mon­day

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.